Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Improved Diagnosis Will Reduce Cost of Sleep Disorders

By HospiMedica staff writers
Posted on 11 Jul 2007
More accurate diagnosis will reduce the direct and indirect costs of sleep disorders in Australia. More...


The direct cost of sleep disorders on the Australian heath system has been estimated at US$34 million dollars a year. Indirect costs of sleep disorders are also high due to, e.g., through road and work accidents.

Griffith University (Queensland, Australia), has been working with Queensland Health (Brisbane, Australia) and the University of Southern Queensland (USQ, Springfield, Australia) to reduce the cost of sleep disorders. Senior lecturer in management at Griffith, Dr Kerr said, Often general practitioners do not have enough information or are not well equipped to deal with the diagnosis of sleep disorders, so they err on the side of caution and refer patients to sleep centers. Health departments spend approximately $257 per night at sleep centers diagnosing patients, which is a costly exercise and ties up valuable resources--particularly as many of these referrals are unnecessary.

Dr Kerr said that his team is working on a project to develop a more effective system of diagnosing sleep disorders. They are investigating and developing a web-based intelligent decision support system to provide a cost-effective solution to this problem. This will help determine if a night at the sleep center is necessary; sleep disorders such as obstructive sleep apnea, periodic limb movement disorder, and associated conditions will be identified.

Patients will be able to enter their information at home, allowing specialists to conduct a preliminary diagnosis and develop a database for follow-up consultations. Hospitals and sleep centers will be equipped with the software for people without access to the Internet at home.


Related Links:
Griffith University

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.